Delivery Order SPE2DB20D9759-SPE2DB24FD5LU
Award Date 5/28/24
Potential Completion Date 6/18/24
Potential Value $3K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the delivery of Lucentis 0.5 mg/0.05 ml syringes to support the medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group, valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $4,633.32 contract is for the delivery of Lucentis 0.5 mg/0.05 ml, a prescription medication, to support the medical supply needs of military health facilities. This delivery order is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,861.10, is for the delivery of LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a performance period through May 29, 2024. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, received a delivery order award from the Defense Logistics Agency (DLA) on April 28, 2025, for Lucentis 0.3 mg/0.05 ml syringes. The contract carries a ceiling value of $1,937.40 under a firm fixed-price delivery order structure with an ultimate completion date of May 19, 2025. This award was made without a set-aside designation, allowing DMS Pharmaceutical Group to compete on its...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $1,544.44, is for the supply of the pharmaceutical product Lucentis 0.5 mg/0.05 ml syringe 0.05 ml. DMS Pharmaceutical Group holds a significant single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,155.24 contract is for the supply of Lucentis 0.3 mg/0.05 ml syringes to fulfill the recurring pharmaceutical needs of military health facilities. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $3,088.88 contract will provide LUCENTIS 0.5 MG/0.05 ML SYRING 0.05ML medical supplies to support the recurring pharmaceutical needs of military health facilities under the DLA's Medical Supply Chain division. This delivery order is part of a larger $499,999,999 indefinite delivery...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order (SPE2DX24F5ZZU) valued at $11,583.30 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide Lucentis 0.5 mg/0.05 ml syringes. This delivery order is part of a larger indefinite delivery contract (SPE2DB), valued up to $499,999,999, that DMS Pharmaceutical Group holds with the DLA to supply a comprehensive range of pharmaceutical products to support the recurring medical...
- The Defense Logistics Agency (DLA) issued a delivery order valued at $2,304.40 to DMS Pharmaceutical Group Inc. for Lucentis 0.3 mg/0.05 mL syringes on January 14, 2026. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is expected to be completed by February 5, 2026,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,083.76 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Lucentis 0.5 mg/0.05 mL syringes. This firm fixed-price delivery order, issued on October 29, 2025, with an ultimate completion date of November 20, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted...